Unique Overlap in the Prerequisites for Thrombin Inhibition and Oral Bioavailability Resulting in Potent Oral Antithrombotics by Adang, Anton E. P, de Man, Adrianus P. A, Vogel, Gerard M. T, Grootenhuis, Peter D. J, Smit, Martin J, Peters, Co A. M, Visser, Arie, Rewinkel, Jos B. M, van Dinther, Theo, Lucas, Hans, Kelder, Jan, van Aelst, Sjoerd, Meuleman, Dick G, van Boeckel, Constant A. A

Get full text

Leveraging Vγ9Vδ2 T cells against prostate cancer through a VHH-based PSMA-Vδ2 bispecific T cell engager by King, Lisa A., Veth, Myrthe, Iglesias-Guimarais, Victoria, Blijdorp, Iris, Kloosterman, Jan, Vis, André N., Roovers, Rob C., Hulsik, David Lutje, Riedl, Thilo, Adang, Anton E.P., Parren, Paul W.H.I., van Helden, Pauline M., de Gruijl, Tanja D., van der Vliet, Hans J.

Get full text

Small molecule biaryl FSH receptor agonists. Part 1: Lead discovery via encoded combinatorial synthesis by Guo, Tao, Adang, Anton E.P., Dolle, Roland E., Dong, Guizhen, Fitzpatrick, Dan, Geng, Peng, Ho, Koc-Kan, Kultgen, Steven G., Liu, Ruiyan, McDonald, Edward, McGuinness, Brian F., Saionz, Kurt W., Valenzano, Kenneth J., van Straten, Nicole C.R., Xie, Dan, Webb, Maria L.

Get full text

A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies by Lameris, Roeland, Ruben, Jurjen M, Iglesias-Guimarais, Victoria, de Jong, Milon, Veth, Myrthe, van de Bovenkamp, Fleur S, de Weerdt, Iris, Kater, Arnon P, Zweegman, Sonja, Horbach, Sjeng, Riedl, Thilo, Winograd, Benjamin, Roovers, Rob C, Adang, Anton E.P, de Gruijl, Tanja D, Parren, Paul W.H.I, van der Vliet, Hans J

Get full text

Small molecule biaryl FSH receptor agonists. Part 2: Lead optimization via parallel synthesis by Guo, Tao, Adang, Anton E.P., Dong, Guizhen, Fitzpatrick, Dan, Geng, Peng, Ho, Koc-Kan, Jibilian, Charles H., Kultgen, Steven G., Liu, Ruiyan, McDonald, Edward, Saionz, Kurt W., Valenzano, Kenneth J., van Straten, Nicole C.R., Xie, Dan, Webb, Maria L.

Get full text

A bispecific γδ T-cell engager targeting EGFR activates a potent Vγ9Vδ2 T cell-mediated immune response against EGFR-expressing tumors by King, Lisa A, Toffoli, Elisa C, Veth, Myrthe, Iglesias-Guimarais, Victoria, Slot, Manon C, Amsen, Derk, van de Ven, Rieneke, Derks, Sarah, Fransen, Marieke F, Tuynman, Jurriaan B, Riedl, Thilo, Roovers, Rob C, Adang, Anton E P, Ruben, Jurjen M, Parren, Paul W H I, de Gruijl, Tanja D, van der Vliet, Hans J

Get full text

Bispecific Vγ9Vδ2-T and Type 1 NKT Cell Engager Lava-051 As First-in-Class Clinical Candidate to Target CD1d Expressing CLL, MM and AML by Lameris, Roeland, Ruben, Jurjen M, Weerdt, Iris de, Roovers, Rob, van de Donk, Niels W.C.J., Broyl, Annemiek, Kater, Arnon P., Riedl, Thilo, Iglesias, Victoria, Winograd, Benjamin, Adang, Anton EP, de Gruijl, Tanja D., Parren, Paul W. H.I., Vliet, Hans J. van der

Get full text

Appropriateness of indications for diagnostic upper gastrointestinal endoscopy: Association with relevant endoscopic disease by Adang, Rob P., Vismans, Jon F-J.F.E., Talmon, Jan L., Hasman, Arie, Ambergen, Anton W., Stockbrügger, Reinhold W.

Get full text

Solution-phase and solid-phase synthesis of novel transition state inhibitors of coagulation enzymes incorporating a piperidinyl moiety by Adang, Anton E.P., Peters, Co A.M., Gerritsma, Siene, de Zwart, Edwin, Veeneman, Gerrit

Get full text

Novel acylguanidine containing thrombin inhibitors with reduced basicity at the P1 moiety by ADANG, A. E. P, LUCAS, H, DE MAN, A. P. A, ENGH, R. A, GROOTENHUIS, P. D. J

Get full text